Skip to content

Enhancing AI tools for smarter symptom analysis in healthcare: A real-world validation study

Optimisation of an AI based clinical decision support system of symptom analysis in clinical settings A prospective validation study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/06/089576
Enrollment
5000
Registered
2025-06-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

Intervention1: Nil: Nil Intervention2: NIL: NIL Intervention3: Nil: Nil Control Intervention1: NIL: NIL

Sponsors

AIIMS RISHIKESH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. OPD and IPD patients under MEDICINE DEPARTMENT of AIIMS RISHIKESH. 2. Patients who give consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Incomplete Data: Cases where data collection is incomplete or compromised leading to gaps in the required information for analysis 2. Patients whose visited MEDICINE department for investigation purpose example medical certificate. 3. Patients whose clinical conditions not eligible for evaluation by the Medicine Department referral cases.

Design outcomes

Primary

MeasureTime frame
1. To validate existing Data-based CDSS symptom repository in OPD and IPD settings by evaluating clinicians real time feedback on the symptom checklistTimepoint: Total duration of Study is 18 months divided in 12 months of Data collection phase and 3 months each for data analysis and data re implementation and analysis phase.

Secondary

MeasureTime frame
1. To predict clinical diagnosis as per expert recommendation. 2. To implement the optimized AI-solution in national portal e-Sanjeevani. 3. To predict department recommendations as per symptom analysis. Timepoint: Total duration of Study is 18 months divided in 12 months of Data collection phase and 3 months each for data analysis and data re implementation and analysis phase.

Countries

India

Contacts

Public ContactDr Prasan Kumar Panda

AIIMS Rishikesh

prasan.med@aiimsrishikesh.edu.in9868999488

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026